No Data
No Data
No Data
No Data
No Data
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Stockhouse Mar 14 05:15
Intellipharmaceutics Announces Cease Trade Order
TORONTO, ON / ACCESSWIRE / March 6, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the resea
AccesswireMar 7 03:45
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the r
AccesswireFeb 27 08:38
Intellipharmaceutics International Inc. Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the re
AccesswireFeb 9 05:35
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
Stockhouse Jan 3 06:40
Intellipharmaceutics International GAAP EPS of -$0.06
Seeking AlphaOct 17, 2023 05:30
No Data
No Data